IBDHorizons® is a nonprofit organization working with a team of experts focusing on Inflammatory Bowel Disease (IBD). Our focus is on education related to the diagnosis, management, and advancement of IBD. We provide accredited educational symposia to areas where access to IBD specialists and experts or centers of excellence in IBD care is limited.
#IBDHorizons25 is gearing up for our 🔟Anniversary celebration in Seattle on March 8! Join @DrScottDLee & @PedsIBD_Wahbeh for our 10th Annual @IBDHorizons PNW Symposium. Our all-star faculty will enlighten us on all the hottest topics in #IBD! Don't get FOMO - register now!
Congratulations to our Abstract 📊📄finalists at the #IBDHorizons25 Midwest symposium! It is our honor to celebrate the research and hard work of the #futureofIBD! 👏🏻
Patient with Crohn’s not responding to 1or 2 Advanced agents:
Likelihood of remitting after 2nd or 3rd advanced agent is <50 %
Likelihood of preventing recurrence after resection 80%
@IBDHorizons Stephen B. Hanauer, MD lecture
IBDHorizons is following all recommended guidelines for in-person gatherings for events with regards to the pandemic. To find out more about COVID-19 visit cdc.gov.
🚨Pub Alert: Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis—A Safety Analysis - Afzali - United European Gastroenterology Journal - Wiley Online Library @UEGJournal https://onlinelibrary.wiley.com/doi/10.1002/ueg2.12745
Congratulations to our Abstract 📊📄finalists at the #IBDHorizons25 Midwest symposium! It is our honor to celebrate the research and hard work of the #futureofIBD! 👏🏻
Leadership lessons from Abraham Lincoln for healthcare leaders: Lead with integrity, make tough decisions with empathy, and navigate challenges with resilience. Just as Lincoln united a divided nation, healthcare leaders must foster collaboration, inspire teams, and drive…
Dr Scott Lee @DrScottDLee educating us about combination advanced therapy CAT in #IBD #SIBD_24
Dr Iles-Shih @SwedishGastro teaching us how to alleviate patient and provider concerns about using biosimilars in #IBD #SIBD_2024
On #WorldIBDDay, #IBDHasNoBorders
Across the globe we are:
👩🏻🏫Educating clinicians & our patients with #IBD
👩🏻🎓Researching treatments
🎗Raising awareness
👷🏻♀️Building #IBDCenters
Together, we fight IBD.
To our patients: We’re 🥊 with you
#WorldIBDay2024 #IBDAwareness
That's a wrap 🎬 1️⃣ City of Roses 🌹 @IBDHorizons X @OregonClinic Symposium. Thank you Dr Don Lum, all Faculty Speakers, Industry Partners and our fantastic, engaged Attendees. See you in 2025, PDX! #IBDHorizons24 Join us for an upcoming Symposium 🔗http://ibdhorizons.org
Higher ustekinumab concentrations associated with less inflammation on cross sectional imaging on #mri in #crohns disease
@DrRosenIBD @UmaMahadevanIBD @ryanungaro
Success! We have received your activity evaluation and application for credit.
When can I expect my credit? Please allow 4-6 weeks from the date of the event for processing.
Who will I hear from? The Annenberg Center for Health Sciences at Eisenhower processes certificates and will email you once the certificate is issued.
Will they email my certificate directly? No, they will email you instructions to download the certificate from their site.
What do I do when the certificate is ready?
Your credit certificates will be stored on the website of our accrediting partner (annenberg.net)
REMINDER
Our team will not have copies of your certificates
Your certificates are linked to the email address provided on the evaluation forms.
Certificates are issued 4-6 weeks after an event
We appreciate your submission into the Research Plenary Session at the 7th Annual IBDHorizons Pacific Northwest Symposium. The program committee looks forward to reviewing each submission carefully. The team will notify about decisions by February 28, 2022 via email. Please check that you received a confirmation email.
For the winners, we are excited to hear your abstracts presented during the 7th Pacific Northwest Symposium on Saturday, March 5, 2022 at the Hyatt Regency Seattle. Further details will be provided by email. Thank you again and don’t forget to register!
We appreciate your submission into the Research Plenary Session at the IBDHorizons Midwest Symposium. The program committee looks forward to reviewing each submission carefully. The team will notify about decisions by January 31, 2024 via email. Please check that you received a confirmation email.
For the winners, we are excited to hear your abstracts presented during the 7th Midwest Symposium on Saturday, February 10, 2024 at the Hyatt Regency Cincinnati. Further details will be provided by email. Thank you again and don’t forget to register!
;
